Solid Biosciences Cash Flow Statement (2017-2026) | SLDB

Cash Flow Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-18.70M-18.03M-18.65M-25.32M-25.09M-20.40M-33.03M-30.35M-24.89M-21.26M-20.61M-24.31M-25.31M-32.94M-38.05M-37.82M-38.79M-45.14M-47.36M-55.24M
Depreciation and Depletion (Quarter)
0.72M0.75M0.76M0.71M0.72M0.44M0.54M0.70M0.70M0.59M0.59M
Share-based Compensation (Quarter)
3.63M3.42M3.42M2.61M1.81M1.52M1.59M2.12M1.94M1.62M1.94M1.61M2.09M3.00M3.82M3.34M3.15M3.93M6.50M5.15M
Gains from Sales and Divestitures (Quarter)
0.42M0.18M0.23M0.24M0.34M0.25M0.28M0.32M0.43M0.52M
Gains from Investment Securities (Quarter)
0.60M0.23M0.32M0.17M0.30M0.01M0.35M0.87M-0.37M0.60M0.42M2.94M-0.00M0.02M0.10M4.38M0.09M
Non-cash Items (Quarter)
0.86M1.00M1.03M0.19M1.34M0.47M1.66M1.08M5.43M
Cash from Operations (Quarter)
-17.10M-18.42M-20.87M-27.19M-15.88M-20.43M-34.48M-28.00M-27.46M-17.90M-20.82M-25.19M-21.47M-23.71M-29.64M-31.85M-37.41M-33.47M-53.55M-47.23M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.53M-0.58M-0.37M-0.15M0.02M0.28M0.21M0.06M0.98M1.15M0.54M1.04M1.21M0.80M0.31M0.49M0.33M0.75M0.62M
Depreciation & Amortization (CF) (Quarter)
0.72M0.75M0.76M0.71M0.72M0.44M0.54M0.70M0.70M0.59M0.59M0.33M1.24M0.41M0.49M0.41M0.39M0.38M0.47M0.40M
Change in Working Capital
Change in Receivables (Quarter)
0.01M0.31M-0.48M-0.10M-0.01M
Change in Account Payables (Quarter)
-0.23M0.96M0.57M0.07M0.30M0.29M-5.91M2.75M-2.71M-0.93M0.13M-0.60M1.07M0.92M0.81M0.46M0.01M3.70M-5.26M2.32M
Change in Accured Expenses (Quarter)
-0.61M-0.30M2.58M-0.45M8.67M-4.97M2.57M-4.91M-1.32M0.91M-1.65M0.21M-0.38M3.31M1.62M-0.28M1.97M2.20M0.15M-0.47M
Other Working Capital Changes (Quarter)
-7.13M8.00M7.61M3.37M-3.95M-2.71M-4.78M-1.26M1.82M-1.69M0.53M-0.47M0.04M0.04M-0.10M-0.42M0.14M0.19M7.65M362.00
Investing Activities
Capital Expenditures (Quarter)
0.01M0.57M-0.52M0.26M0.34M-0.38M0.31M0.51M-0.36M-0.14M1.51M0.15M-0.13M0.02M-0.04M0.08M0.42M-0.17M-0.28M0.03M
Cash from Investing Activities (Quarter)
-48.72M-72.51M30.18M37.74M-59.59M14.91M66.10M37.26M-48.23M-24.64M45.30M-38.49M-5.18M-10.99M38.57M-27.46M-32.73M-45.27M47.01M44.76M
Financing Activities
Other financing activities (Quarter)
4.83M0.29M12.89M
Cash from Financing Activities (Quarter)
-0.24M0.00M0.07M0.02M0.07M-0.00M74.74M0.51M107.24M5.00M3.26M6.94M189.73M-1.60M1.18M5.14M239.03M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Change in Cash (Quarter)
-66.06M-90.93M9.37M10.57M-75.40M-5.52M106.36M9.27M-73.08M-42.53M24.98M43.56M-21.64M-31.44M15.86M130.41M-71.75M-77.57M-1.40M236.56M
Free Cash Flow (Quarter)
-17.11M-19.00M-20.36M-27.45M-16.21M-20.05M-34.79M-28.50M-27.10M-17.76M-22.34M-25.34M-21.34M-23.72M-29.61M-31.93M-37.84M-33.30M-53.27M-47.26M
Net Cash Flow (Quarter)
-66.06M-90.93M9.37M10.57M-75.40M-5.52M106.36M9.27M-75.70M-42.53M24.98M43.56M-21.64M-31.44M15.86M130.41M-71.75M-77.57M-1.40M236.56M